Mphasis Ltd
MPHASISMphasis Ltd's earnings have outrun its stock. EPS grew +9.0% in a year against a −15.5% price move.
The sharpest disagreement: Promoters moved −9.8 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a downtrend (21 weeks in) while the P/E sits at the 46th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +10.9% year on year, and 104% of the last 3 years' profit arrived as cash. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Mphasis Ltd trades at ₹2,394, in a downtrend and 21 weeks into that stage. That is −2.0% against its own 200-day average. It sits at 34% of a 52-week range of ₹2,083 to ₹2,994. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 3 straight weeks.
Today the stock is in a downtrend — week 21 of stage 4, confirmed. At ₹2,394 it trades −2.0% versus its 200-day average and sits at 34% of its 52-week range (₹2,083–₹2,994).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +434% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 46th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Mphasis Ltd trades at 22.6× P/E, mid-range by its own standards (46th percentile). Its long-run median P/E is 23.5×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 22.6× is mid-range by its own standards (46th percentile), against a long-run median of 23.5× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +9.0% against a −15.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +0.0%/yr price move, ~+8.2%/yr came from earnings growth and ~−8.2 pp from the multiple (compressing); over 10y, of the +16.1%/yr price move, ~+11.1%/yr came from earnings growth and ~+5.0 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Mphasis Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 24.4% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.6% | +4.8% | +10.3% | +10.1% |
| Profit | +9.5% | +4.4% | +8.9% | +11.4% |
| EPS | +9.0% | +3.9% | +8.5% | +12.5% |
| Share price | −15.5% | +5.0% | +0.0% | +16.1% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
46.7/100 — rank 39 of 63 in IT - Software · 94% evidence confidence
Mphasis Ltd scores 46.7 out of 100 against the 63 companies it is compared with in IT - Software, ranking 39. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 15.2 + 15.6 + 5.6 + 10.3 = 46.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Mphasis Ltd reported ₹4,384 Cr of revenue in the Jun 26 quarter, +17.5% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 10.1% a year. The last full year, FY26, came in at ₹15,880 Cr. The last four reported quarters add to ₹16,532 Cr.
Mphasis Ltd reported ₹4,384 Cr of revenue in the Jun 26 quarter, +17.5% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 10.1% a year. The last full year, FY26, came in at ₹15,880 Cr. The last four reported quarters add to ₹16,532 Cr.
FY26 revenue came in at ₹15,880 Cr (+11.6% on the year), capping 10 years at 10.1% compound. The latest quarter (Jun 26) printed ₹4,384 Cr, +17.5% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +13.7% growth against the decade's 10.1% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +13.7% over the last 4 quarters against +10.9%/yr over the last 8 — stabilising; TTM profit +9.9% vs +10.5%/yr — stabilising.
→ Revenue grew — did margins hold as it scaled? Next: 18.0% this quarter (−1.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Mphasis Ltd's operating margin is 18.0% in the Jun 26 quarter, −1.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 14.0% to 19.0%. The current quarter sits inside that band.
Mphasis Ltd's operating margin is 18.0% in the Jun 26 quarter, −1.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 14.0% to 19.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 18.0%, −1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 14.0%–19.0%, and FY26's 19.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −0.7 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
→ Margins slipped — did that reach the bottom line? Next: profit +10.9% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Mphasis Ltd earned ₹490 Cr of net profit in the Jun 26 quarter, +10.9% year on year. It is the 9th consecutive quarter of growth. Full-year FY26 profit was ₹1,863 Cr. The 10-year compound rate is 11.4%. That is 11.2% of the quarter's revenue. The same quarter a year earlier earned ₹442 Cr.
Mphasis Ltd earned ₹490 Cr of net profit in the Jun 26 quarter, +10.9% year on year. It is the 9th consecutive quarter of growth. Full-year FY26 profit was ₹1,863 Cr. The 10-year compound rate is 11.4%. That is 11.2% of the quarter's revenue. The same quarter a year earlier earned ₹442 Cr.
Jun 26 profit was ₹490 Cr, +10.9% year on year — the 9th consecutive quarter of growth. On the full year, FY26 printed ₹1,863 Cr (+9.5%), and the 10-year compound rate is 11.4%.
Why profit moved: revenue contributed +17.5% and the margin −1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +9.8% vs revenue +13.7%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit rose — but did the cash follow? Next: 104% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 104% of Mphasis Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹1,253 Cr of operating cash against ₹1,863 Cr of profit. After ₹1,209 Cr of capital spending, ₹44.0 Cr was left as free cash.
FY26: operating cash of ₹1,253 Cr against reported profit of ₹1,863 Cr, leaving free cash of ₹44.0 Cr after ₹1,209 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 104% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 104%: the cash cycle stretched 61 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 2.6× depreciation over three years, so the next section's job is to check what that build-out is buying.
→ So follow the cash to where it goes. Next: ₹3,784 Cr of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Mphasis Ltd's cash conversion cycle runs 96 days in FY26, up from 35 days in FY21. Capital spending ran ₹3,784 Cr over the last 3 years. At FY26 sales of ₹15,880 Cr each day of that cycle holds about ₹43.5 Cr, so roughly ₹4,177 Cr sits inside the business at any moment.
FY26: debtors at 96 days (an asset-light business — no inventory to speak of) — for a full cycle of 96 days, looser than FY21's 35.
In money terms: at FY26 sales of ₹15,880 Cr, each day of the cycle holds about ₹43.5 Cr — so the 96-day loop keeps roughly ₹4,177 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹3,784 Cr over the last 3 fiscal years against ₹1,441 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 22% and the ROIC − WACC spread is +5.6 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Mphasis Ltd earns a ROCE of 22% in FY26. That is up from a trough of 15% in FY16. Return on invested capital clears the cost of that capital by +5.6 percentage points, so growth here adds value rather than only size. The wiring behind it is 11.7% net margin on 0.90× asset turns.
FY26 ROCE is 22%, recovered from a FY16 trough of 15% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 11.7% net margin × 0.90× asset turns × 1.64× balance-sheet leverage ≈ 17.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 17.6% − 12.0% = a +5.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.24.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Mphasis Ltd carries total debt of ₹2,620 Cr against shareholder equity of ₹10,744 Cr as of Mar 26, a debt-to-equity of 0.24 — effectively unlevered. On the annual view that ratio went from 0.18 in FY22 to 0.24 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹2,620 Cr against shareholder equity of ₹10,744 Cr — a debt-to-equity of 0.24. On the annual view, debt-to-equity went from 0.18 (FY22) to 0.24 (FY26). The returns on this page are earned, not borrowed.
→ Who owns this, and are they adding or leaving? Next: Promoters cut 9.8 points over 8 quarters.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 9.8 points of Mphasis Ltd over 8 quarters, the biggest move on the register. That takes promoters to 30.5% of the company. Domestic institutions moved +9.5 points over the same window, to 45.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −9.8 points over 8 quarters to 30.5%; Domestic institutions: +9.5 points over 8 quarters to 45.3%; Foreign institutions: +1.2 points over 8 quarters to 19.5%.
🚨 Why the register moved: promoters drove it (−9.8 points), absorbed on the other side by domestic institutions (+9.5 points) — distribution into the market’s bid.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Mphasis Ltd: the Z-score reads 6.52. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 6.52 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 6.52.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Mphasis Ltd this page | 22.6× | ₹43,674 Cr | Consistent | |||
| Tata Consultancy Services Ltd | 15.2× | ₹8.2L Cr | Consistent | |||
| Infosys Ltd | 13.6× | ₹4.2L Cr | Consistent | |||
| HCL Technologies Ltd | 19.0× | ₹3.4L Cr | Mixed | |||
| Wipro Ltd | 13.3× | ₹1.8L Cr | Topping out | |||
| Tech Mahindra Ltd | 28.7× | ₹1.5L Cr | Topping out | |||
| LTM Ltd | 21.6× | ₹1.2L Cr | Consistent | |||
| Coforge Ltd | 40.0× | ₹65,726 Cr | Mixed | |||
| Hexaware Technologies Ltd | 23.0× | ₹33,719 Cr | No read | |||
| IDream Film Infrastructure Company Ltd | — | ₹17,180 Cr | No read | |||
| Zensar Technologies Ltd | 15.1× | ₹11,511 Cr | Turning around | |||
| Sonata Software Ltd | 15.8× | ₹8,079 Cr | Mixed | |||
| Tanla Platforms Ltd | 14.9× | ₹7,954 Cr | Turning around | |||
| Birlasoft Ltd | 14.8× | ₹7,896 Cr | Turning around | |||
| Seshaasai Technologies Ltd | 23.6× | ₹6,221 Cr | No read | |||
| ASM Technologies Ltd | 103.0× | ₹6,206 Cr | No read | |||
| AvenuesAI Ltd | 20.2× | ₹5,700 Cr | Mixed | |||
| Mastek Ltd | 12.0× | ₹5,242 Cr | Consistent | |||
| Datamatics Global Services Ltd | 20.3× | ₹4,856 Cr | Topping out | |||
| Aurionpro Solutions Ltd | 21.0× | ₹4,562 Cr | Mixed | |||
| Moschip Technologies Ltd | 141.0× | ₹4,508 Cr | Mixed | |||
| Capillary Technologies India Ltd | 128.0× | ₹3,790 Cr | — | — | — | — |
| TechNVision Ventures Ltd | 984.0× | ₹3,563 Cr | No read | |||
| Cigniti Technologies Ltd | 11.4× | ₹3,472 Cr | Mixed | |||
| 63 Moons Technologies Ltd | — | ₹3,264 Cr | No read | |||
| ASM Technologies Ltd | 52.8× | ₹3,220 Cr | No read | |||
| TechNVision Ventures Ltd | 14,485.0× | ₹3,187 Cr | No read | |||
| R Systems International Ltd | 12.6× | ₹2,909 Cr | Turning around | |||
| Sasken Technologies Ltd | 48.1× | ₹2,765 Cr | Improving | |||
| BLS E-Services Ltd | 44.6× | ₹2,565 Cr | Mixed | |||
| Silver Touch Technologies Ltd | 71.0× | ₹2,538 Cr | Turning around | |||
| Saksoft Ltd | 16.3× | ₹2,231 Cr | Mixed | |||
| Blue Cloud Softech Solutions Ltd | 31.2× | ₹1,889 Cr | Mixed | |||
| Hypersoft Technologies Ltd | 440.0× | ₹1,798 Cr | No read | |||
| Kody Technolab Ltd | 104.0× | ₹1,748 Cr | — | — | — | — |
| IZMO Ltd | 34.8× | ₹1,653 Cr | Improving | |||
| NINtec Systems Ltd | 50.3× | ₹1,610 Cr | Mixed | |||
| Dynacons Systems & Solutions Ltd | 18.6× | ₹1,580 Cr | Mixed | |||
| Magellanic Cloud Ltd | 13.6× | ₹1,568 Cr | Mixed | |||
| InfoBeans Technologies Ltd | 18.0× | ₹1,526 Cr | Mixed |
Frequently asked questions
What is Mphasis Ltd's share price today?
Mphasis Ltd trades at ₹2,394, −15.5% over the past year. The company is valued at ₹43,674 Cr. The stock sits at 34% of its 52-week range of ₹2,083–₹2,994, −2.0% versus its 200-day average. On the tape, the price is in a downtrend, 21 weeks in. — as of 24 July 2026.
What were Mphasis Ltd's latest quarterly results?
Mphasis Ltd reported revenue of ₹4,384 Cr and net profit of ₹490 Cr for the Jun 26 quarter. Revenue rose 17.5% and profit rose 10.9% year on year. Earnings per share were ₹25.65. The operating margin was 18.0%, 1.0 pp lower than a year earlier. — as of 24 July 2026.
What is Mphasis Ltd's revenue?
Mphasis Ltd reported revenue of ₹4,384 Cr in the Jun 26 quarter, +17.5% year on year. For the full FY26 fiscal year, revenue was ₹15,880 Cr (+11.6%). Over the last 10 years revenue compounded at 10.1% a year. — as of 24 July 2026.
What is Mphasis Ltd's profit?
Mphasis Ltd earned ₹490 Cr of net profit in the Jun 26 quarter, +10.9% year on year — the 9th straight quarter of growth. Full-year FY26 profit was ₹1,863 Cr. The operating margin ran 18.0% in the latest quarter. — as of 24 July 2026.
What is Mphasis Ltd's market cap?
Mphasis Ltd's market capitalisation is ₹43,674 Cr at a share price of ₹2,394. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Mphasis Ltd's P/E ratio?
Mphasis Ltd trades at a P/E of 22.6×, at the 46th percentile of its own 10-year range, against a long-run median of 23.5×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Mphasis Ltd pay a dividend?
Yes — Mphasis Ltd's dividend payout was 64% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is Mphasis Ltd overvalued?
On its own history, Mphasis Ltd looks mid-range against its own history: its P/E of 22.6× sits at the 46th percentile of its 10-year range (long-run median 23.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 24 July 2026.
Is Mphasis Ltd growing?
Yes — Mphasis Ltd is growing: latest-quarter revenue +17.5% year on year, profit +10.9%, and the margin −1.0 pp at 18.0%. The 10-year compound rates are 10.1% (revenue) and 11.4% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is Mphasis Ltd performing?
Mphasis Ltd is in a downtrend, 21 weeks in. Its latest quarter's revenue rose 17.5% and profit rose 10.9% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is Mphasis Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 24.4% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +13.7% latest, profit growth +9.9% latest, eps growth +9.4% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Mphasis Ltd in an uptrend?
No — the price is in a downtrend (week 21 of stage 4), trading −2.0% versus its 200-day average and at 34% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Mphasis Ltd beating the market?
On recent form, yes — Mphasis Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +434% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 24 July 2026.
Will Mphasis Ltd's share price go up?
This page publishes no price forecast for Mphasis Ltd. What it measures instead: the share price is ₹2,394, the price is in a downtrend 21 weeks in. Its P/E of 22.6× sits at the 46th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 24 July 2026.
Who owns Mphasis Ltd?
Promoters hold 30.5% of Mphasis Ltd, foreign institutions 19.5%, domestic institutions 45.3% and the public 4.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 9.8 points over 8 quarters. — as of 24 July 2026.
Does Mphasis Ltd have too much debt?
No — Mphasis Ltd's debt-to-equity is 0.24, and operating profit covers the interest bill 15×. FY26 borrowings were ₹2,620 Cr against equity of ₹10,744 Cr. The returns on this page are earned, not borrowed — as of 24 July 2026.
What is Mphasis Ltd's capex?
Mphasis Ltd spent ₹3,784 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1,209 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Mphasis Ltd's cash flow?
Mphasis Ltd generated ₹1,253 Cr of operating cash flow in FY26 and ₹44.0 Cr of free cash flow after ₹1,209 Cr of capital spending. Reported profit that year was ₹1,863 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Mphasis Ltd's profit real cash?
Yes — over the last 3 fiscal years, 104% of Mphasis Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹1,253 Cr against reported profit of ₹1,863 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 24 July 2026.
How financially safe is Mphasis Ltd?
On the balance sheet, the Z-score reads 6.52 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 24 July 2026.
Where is Mphasis Ltd in its business cycle?
Mphasis Ltd's FY26 operating margin was 19.0%, against a 13-year band of 14.0%–19.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 18.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Mphasis Ltd story?
The sharpest disagreement: Promoters moved −9.8 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Mphasis Ltd a stock worth studying right now?
This is not investment advice. The machine read: Mphasis Ltd's earnings have outrun its stock. EPS grew +9.0% in a year against a −15.5% price move. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.